Fenfluramine and Idiopathic Pain: A Serotonergic Study in Non-Psychiatric Patients with Functional Gastrointestinal Disorder

References

• Drossman DA, Thompsom GW, Talley NJ, Funck-Jensen P, Janssens J, Whitehead WE. Identification of subgroups of functional gastrointestinal disorders. Gastroenterology 1990; 3: 159–72.
   Google Scholar
• Kay L, Jorgensen T, Schultz-Larsen K, Davidsen M. Irritable bowel syndrome and upper dyspepsia among the elderly: a study of symptom clusters in a random 70 year old population. Eur J Epidemiol. 1996; 12: 199–204.
   Google Scholar
• Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671–80.
   PubMed Web of Science ®Google Scholar
• Smith RC, Greenbaum DS, Vancouver JB, Henry RC, Reinhart MA, Greenbaum RB, et al. Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology 1991; 100: 591–595.
   PubMedGoogle Scholar
• Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997; 92: 954–9.
   Google Scholar
• Maxton DG, Morris J, Whorwell PJ. Selective 5-hydroxytrypta-mine antagonism: a role in irritable bowel syndrome and functional dyspepsia? Aliment Pharmacol Ther 1996; 10: 595–9.
   Google Scholar
• Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalised disorder of gut sensitivity. Dig Dis Sci 1995; 40: 1607–13.
   Google Scholar
• Thompson WG. Gender differences in irritable bowel symptoms. Eur J Gastroenterol Hepatol 1997; 9: 299–302.
   PubMed Web of Science ®Google Scholar
• Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut 1987; 28: 1307–18.
   PubMed Web of Science ®Google Scholar
• Brook A. Bowel distress and emotional conflict. J R Soc Med 1991; 84: 39–42.
   PubMed Web of Science ®Google Scholar
• Platz T, Junkert B, Tress W, Schepank H. Is there a typical conflict in gastric complaints? An epidemiological-psychoanalytic contribution to the question of conflict specificity in psychosomatic medicine. Psychother Psychosom 1993; 59: 165–72.
   PubMedGoogle Scholar
• Haug TT, Svebak S, Wilhelmsen I, Berstad A, Ursin H. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosomatic Res 1994; 38: 281–91.
   Google Scholar
• Dewsnap P, Gomborone J, Libby G, Farthing M. The prevalence of irritable bowel syndrome among acute psychiatric inpatients with an affective diagnosis. Psychosomatics 1996; 37: 385–9.
   PubMedGoogle Scholar
• Westerberg L, Theorell T. Working conditions and family situation in relation to functional gastrointestinal disorders. The Swedish Dyspepsia Project. Scand J Prim Health Care 1997; 15: 76–81.
   PubMed Web of Science ®Google Scholar
• Hislop IG. Psychological significance of the irritable colon syndrome. Gut 1971; 12: 452–7.
   PubMed Web of Science ®Google Scholar
• Craig TKJ, Brown GW. Goal frustration and life events in the aetiology of painful gastrointestinal disorder. J Psychosom Res 1984; 28: 411–21.
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825–30.
   Google Scholar
• Haug TT, Wilhelmsen I, Berstad A, Ursin H. Life events and stress in patients with functional dyspepsia compared with patients with duodenal ulcer and healthy controls. Scand J Gastroenterol 1995; 30: 524–30.
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psych 1989; 46: 587–99.
   PubMed Web of Science ®Google Scholar
• Stoff DM, Pasatiempo AP, Yeung J, Cooper TB, Bridger WH, Rabinovich H. neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents. Psychiatry Res 1992; 43: 263–76.
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Silverman JM, Klar Hm, Horvath TB, Siever LJ. Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psych 1994; 51: 318–24.
   Google Scholar
• Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry 1997; 154: 1430–5.
   PubMed Web of Science ®Google Scholar
• Cleare AJ, Bond AJ. Does central serotonergic function correlate inversely with aggression? A study using D-fenflur-amine in healthy subjects. Psychiatry Res 1997; 69: 89–95.
   PubMed Web of Science ®Google Scholar
• Dinan TG. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci 1996; 58: 1683–94.
   PubMed Web of Science ®Google Scholar
• Eccleston D, Doogan D. Serotonin and behavioral disorders. Br J Psychiatry 1989; 8 Suppl: 7–69.
   Google Scholar
• Lewis DA, Sherman BM. Serotonergic regulation of prolactin and growth hormone secretion in man. Acta Endocrinol (Copenh) 1985; 110: 152–7.
   PubMedGoogle Scholar
• Rowland NE, Carlton J. Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 1986; 27: 13–62.
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects. Neuropsychopharmacology 1996; 15: 595–607.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Williams JBW, Gibbon M, First MB Structured Clinical Interview for DSM-III-R: non-patient edition. Washington (DC): American Psychiatric Press: 1990.
   Google Scholar
• Snaith RP, Harçop FM, Newby DA, Teale C. Grade scores of the Montgomery-Åsberg Depression and the Clinical Anxiety Scales. Br J Psychiatry 1986; 148: 599–601.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.
   PubMed Web of Science ®Google Scholar
• Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653–4.
   PubMed Web of Science ®Google Scholar
• Nesland Aa, Berstad A. Erosive prepyloric changes in persons with and without dyspepsia. Scand J Gastroenterol 1985; 20: 222–8.
   PubMed Web of Science ®Google Scholar
• Targum SD, Marshall LE. Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res. 1989; 28: 295–306.
   PubMedGoogle Scholar
• Targum SD. Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol Psychiatry 1990; 28: 21–34.
   PubMedGoogle Scholar
• Targum SD. Cortisol response during different anxiogenic challenges in panic disorder patients. Psychoneuroendocrinology 1992; 7: 453–8.
   Google Scholar
• Gorard DA, Taylor TM, Medbak SH, Perry LA, Libby GW, Farthing MJ. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fen-fluramine or placebo to healthy subjects. Int Clin Psychopharmacol 1993; 8: 123–8.
   PubMed Web of Science ®Google Scholar
• Dinan TG, Yatham LN, Barry S, Chua A, Keeling PWN. Serotonin supersensitivity: the pathophysiologic basis of nonulcer dyspepsia. Scand J Gastroenterol 1990; 25: 541–4.
   Google Scholar
• Chua A, Keating J, Hamilton D, Keeling PWN, Dinan TG. Central serotonin receptors and delayed gastric emptying in nonulcer dyspepsia. Br Med J 1992; 305: 280–2.
   Google Scholar
• Muldoon MF, Manuck SB, Jansma CL, Moore AL, Perel J, Mann JJ. D,L-fenfluramine challenge test: experience in nonpatients sample. Biol Psychiatry 1996; 39: 761–8.
   PubMedGoogle Scholar
• Wetzel H, Wiesner J, Hiemke C, Benkert O. Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers. J Psychiatr Res 1994; 28: 461–73.
   PubMed Web of Science ®Google Scholar
• Garbutt JC, Mayo JP, Little KY, Gillette GM, Mason GA, Dew B, et al. Dose-response studies with protirelin. Arch Gen Psychiatry 1994; 51: 875–83.
   PubMedGoogle Scholar
• Balsa JA, Sanchez-Franco F, Lorenzo MJ, Pazos F, Cacicedo L. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion. Endocrinology 1996; 137: 508–13.
   PubMedGoogle Scholar
• Watanobe H, Sasaki S. Effect of thyroid status on the prolactinreleasing action of vasoactive intestinal peptide in humans: comparison with the action of thyrotropin-releasing hormone. Neuroendocrinology 1995; 61: 207–12.
   PubMedGoogle Scholar
• Roberts JE. Visible light induced changes in the immune response through an eye-brain mechanism (photeneuroimmunology). J Photechem Photobiol B 1995; 29: 3–15.
   PubMed Web of Science ®Google Scholar
• Larsen PJ, Vrang PJ, Moller M, Jessop DS, Lightman SL, Chowdrey HS, et al. The diurnal expression of genes encoding vasopressin and vasoactive intestinal peptide within the rat suprachiasmatic nucleus is influenced by circulating glucocorticoids. Brain Res Mol Brain Res 1994; 27: 342–6.
   PubMedGoogle Scholar
• Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 1993; 150: 83–6.
   PubMed Web of Science ®Google Scholar
• Armario A, Marti O, Gavalda A, Giralt M, Jolin T. Effects of chronic immobilization stress on GH and TSH secretion in the rat: response to hypothalamic regulatory factors. Psychoneuroendocrinology 1993; 18: 405–13.
   Google Scholar